AbbVie, Inc. (ABBV)

107.74
NYSE
Prev Close 107.33
Day Low/High 105.36 / 108.58
52 Wk Low/High 62.55 / 113.41
Exchange NYSE
Shares Outstanding 1765.88B
Market Cap 189.53B
P/E Ratio 90.13
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: You Just Won Powerball, Now What?

Jim Cramer: You Just Won Powerball, Now What?

Remember, you only need to get rich once.

8 Quality Dividend Stocks for Durable Growth and Income

8 Quality Dividend Stocks for Durable Growth and Income

Four experts highlight their favorite dividend stocks for 2021.

Jim Cramer: 10 Big Dividend Stocks I Like Now

Jim Cramer: 10 Big Dividend Stocks I Like Now

I think investors deserve much better than to say that there's no opportunity for income in this market.

AbbVie Is a Stock to Position for 2021

AbbVie Is a Stock to Position for 2021

Let's review the charts and indicators.

Jim Cramer: 10 Investment Themes I Like in 2021

Jim Cramer: 10 Investment Themes I Like in 2021

I am talking about themes that can stand the test not of today, or tomorrow, but for all of 2021 and beyond.

I Dislike Picking a Top Pick for the Year, but Here Is Mine for 2021

I Dislike Picking a Top Pick for the Year, but Here Is Mine for 2021

It's a stock that underperformed the last two years but would likely excel in a year of renewed growth in economic activity.

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.

Jim Cramer: The 10 Tipping Points That Took Us to Dow 30,000

Jim Cramer: The 10 Tipping Points That Took Us to Dow 30,000

All in all stick with the tipping pointers, they are the drivers of this and the next leg higher.

November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks

November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks

Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.

AbbVie Rated New Outperform at BMO

My Election Day Wish, Tech Sector Performance, Trading Amazon and 6 Other Stocks

My Election Day Wish, Tech Sector Performance, Trading Amazon and 6 Other Stocks

Here's to the removal of uncertainty -- and thousands of campaign signs on thousands of lawns in my neighborhood.

Pausing for Thought, Parsing GDP, Laying Out a Game Plan, Sizing Up Big Tech

Pausing for Thought, Parsing GDP, Laying Out a Game Plan, Sizing Up Big Tech

Plus, we check out up the bevy of reasons for this week's negative market behavior.

Immatics Is a Bit Boy Who Cried Wolf

Immatics Is a Bit Boy Who Cried Wolf

This is the type of chart that will grab the attention of momentum traders.

This Dividend Stock's Got the Right Medicine for Investors

This Dividend Stock's Got the Right Medicine for Investors

AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector.

Weakening Dollar, Fiscal Relief Gridlock, Walmart+, Trading Albemarle

Weakening Dollar, Fiscal Relief Gridlock, Walmart+, Trading Albemarle

Also, interpreting Tuesday's market, Covid-19 vaccine update, and manufacturing growth.

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Stay Patient With AbbVie

Stay Patient With AbbVie

I would continue to hold ABBV, and here's why.

2 Biotech Stocks to Buy on Solid Q2 Results

2 Biotech Stocks to Buy on Solid Q2 Results

Covid-19 has had a big impact on this sector, but these names have strong catalysts going into the next quarter.

Let's Not Overlook AbbVie's Q2 Beat

Let's Not Overlook AbbVie's Q2 Beat

There is no thought of selling here and now, even with politicized pressure on the industry.

Grotesque GDP, So Much for Rotation, Amazon Goes Wild: Market Recon

Grotesque GDP, So Much for Rotation, Amazon Goes Wild: Market Recon

Plus, it could be quite a while before the labor market can absorb all those people who are out of jobs.

7 Drug Stocks With the Right Medicine for Investors

7 Drug Stocks With the Right Medicine for Investors

These pharmaceutical favorites continue to make progress on a number of fronts including a Covid-19 vaccine.

SPACs Aren't Just for Trading: 2 Attractive Buy and Hold Opportunities

SPACs Aren't Just for Trading: 2 Attractive Buy and Hold Opportunities

I like putting some of my money with incredibly successful folks who are well-connected and have a history of success.

AbbVie Is Concocting a Formula for a Breakout

AbbVie Is Concocting a Formula for a Breakout

Here's an updated strategy for ABBV, which could see new highs soon.

The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance

The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance

I have always liked the aggressive management.

The Charts of AbbVie Can Reach New Heights

The Charts of AbbVie Can Reach New Heights

A lifting on the moratorium on elective procedures could be a big win for ABBV.

Jim Cramer: This Opening Is the Beginning of the End of the Healthcare Recession

Jim Cramer: This Opening Is the Beginning of the End of the Healthcare Recession

What's really driving the market, what's making the Nasdaq roar? Tech and science, that's what.

Markets Test Support Levels, Amazon Earnings, Calibrating for Covid-19

Markets Test Support Levels, Amazon Earnings, Calibrating for Covid-19

The market sold off on Thursday after close as big hitters, including Amazon, reported earnings.